Pain and function improved with Hyalgan in treatment of knee OA in the Asian population .
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2013;1(18):20. 2011 ;():.
200 patients were randomized to investigate the efficacy of sodium hyaluronate in the treatment of knee osteoarthritis in the Asian population. Patients were allocated to receive 5 weekly intra-articular (i.a.) injections of Hyalgan or saline placebo, and were followed-up for 20 weeks afterward. The results indicated that patients who were treated with i.a. sodium hyaluronate experienced significantly improved pain and function compared to those treated with placebo saline solution.
Was the allocation sequence adequately generated?
Was allocation adequately concealed?
Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?
Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?
Blinding Patients: Was knowledge of the allocated interventions adequately prevented?
Was loss to follow-up (missing outcome data) infrequent?
Are reports of the study free of suggestion of selective outcome reporting?
Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?
Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?
Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?
Sim = 1
Incerto = 0,5
Não relevante = 0
Não = 0
A Avaliação dos Critérios de Relato avalia a transparência com que os autores relatam as caraterísticas metodológicas e do ensaio na publicação. A avaliação está dividida em cinco categorias que são apresentadas de seguida.
2/4
Randomization
3/4
Outcome Measurements
4/4
Inclusion / Exclusion
2/4
Therapy Description
4/4
Statistics
Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65
O Índice de Fragilidade é uma ferramenta que auxilia na interpretação de achados significativos, fornecendo uma medida de força para um resultado. O Índice de Fragilidade representa o número de eventos consecutivos que precisam de ser adicionados a um resultado dicotómico para que o resultado deixe de ser significativo. Um número pequeno representa um resultado mais fraco e um número grande representa um resultado mais forte.
Porque é que este estudo era necessário agora?
Common primary treatment of knee osteoarthritis usually consists of simple analgesics, but when pain can no longer be effectively reduced, a therapy of nonsteroidal anti-inflammatory drugs (NSAIDs) is adopted. Although NSAIDs possess well documented pain relief and anti-inflammatory effects, serious gastrointestinal side-effects have been reported with their use. A preferential alternative to NSAIDs has been intra-articular injections of sodium hyaluronate (Hyalgan), but despite extensive research on a worldwide scale, only one study has been dedicated to investigating the efficacy of such treatment in an Asian population.
Qual era a principal questão de investigação?
Did 5 weekly intra-articular injections of 20-mg/2mL sodium hyaluronate effectively reduce pain compared to 2mL of placebo saline solution, when measured after 25 weeks from the beginning of therapy?
- Pain (VAS) on the 50 foot walking test was reduced from 45.15mm to 21.53mm (baseline to week 25) in the placebo group and 47.85mm to 17.00mm in the Hyalgan group. The difference in pain at week 25 (P=0.035) and the overall reduction of pain (0.002) were statistically significant, favoring the Hyalgan group.
- Pain and function, as assessed by WOMAC subscales, was significantly reduced with sodium hyaluronate compared to the placebo (P=0.0050 and 0.0038, respectively). Significance was detected by week 5 and carried through for the remainder of the study.
- Although WOMAC stiffness scores were generally more improved in the Hyalgan group, there was no significant difference in this outcome between groups for the duration of the study.
- Both groups achieved slight reduction from baseline 50-foot walking test, with no significant difference.
- No difference was observed in the amount of synovial fluid of the knee between treatment groups.
- Patient and investigator rating of therapy effectiveness did not significantly differ between groups.
- There was no difference in acetaminophen consumption between groups for the duration of the study.
De que é que me devo lembrar mais?
The 5-injection administration of 20-mg/mL sodium hyaluronte provided improved pain (100-mm and WOMAC subscale) and function (WOMAC subscale) compared to saline placebo in an Asian population. Difference was detected after 5 weeks and held through to the end of the study at 25 weeks.
Como é que isto afectará o tratamento dos meus doentes?
The results of this study support the use of sodium hyaluronate for the treatment of knee osteoarthritis in the Asian population. For a more robust understanding of the efficacy of Hyalgan in the Asian population, future studies should consider outcomes in the long-term and employ Minimum Important Differences (MIDs).
AVISO LEGAL
O conteúdo desta página destina-se apenas a fins informativos e não pretende substituir o aconselhamento, diagnóstico ou tratamento médico profissional. Se necessitar de tratamento médico, procure sempre o conselho do seu médico ou dirija-se ao serviço de urgência mais próximo. As opiniões, crenças e pontos de vista expressos pelos indivíduos no conteúdo encontrado nesta página não reflectem as opiniões, crenças e pontos de vista da OrthoEvidence.
0 de 4 artigos mensais GRATUITOS desbloqueados
